Cargando…
BPC 157 as Potential Treatment for COVID-19
The emergence of coronavirus disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. COVID-19 is largely seen as a thrombotic and vascular disease targeting endothelial cells (ECs) throughout the body that can provoke the breakdown of central vascular functions. This expla...
Autor principal: | Deek, Sarah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575535/ https://www.ncbi.nlm.nih.gov/pubmed/34798584 http://dx.doi.org/10.1016/j.mehy.2021.110736 |
Ejemplares similares
-
Pentadecapeptide BPC 157 and the central nervous system
por: Vukojević, Jakša, et al.
Publicado: (2021) -
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
por: Seiwerth, Sven, et al.
Publicado: (2021) -
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
por: Kralj, Tamara, et al.
Publicado: (2021) -
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
por: Sikiric, Predrag, et al.
Publicado: (2016) -
The anti-nociceptive effect of BPC-157 on the incisional pain model in rats
por: Jung, Young-Hoon, et al.
Publicado: (2022)